Oct 19 (Reuters) - France's bioMérieux BIOX.PA will
invest 70 million pounds ($85 million) in Britain's Oxford
Nanopore Technologies ONT.L , the companies said in a joint
statement on Thursday.
The medical diagnostic technology firm also expects to make
further purchases up to 3.5% of Oxford Nanopore stock, they
said.
Oxford Nanopore, a leader in in vitro diagnostics, also
reconfirmed it aims for breakeven adjusted EBITDA by the end of
2026.
(Reporting by Pierre John Felcenloben; editing by Jason Neely)
((PierreJohn.Felcenloben@thomsonreuters.com;))